TC Medical(SH:600763) Sou Hu Cai Jing·2025-10-17 11:53Core Viewpoint - Tongce Medical (600763) experienced a decline in stock price, closing at 41.95 yuan on October 17, 2025, down 2.96% with significant net outflow of main funds [1][2] Fund Flow Summary - On October 17, 2025, main funds had a net outflow of 53.99 million yuan, accounting for 18.18% of total trading volume, while retail investors saw a net inflow of 46.08 million yuan, representing 15.52% of total trading volume [1][2] - Over the past five days, the stock has seen fluctuating fund flows, with the highest net outflow of main funds recorded on October 17, 2025, at 53.99 million yuan [2] Company Performance Metrics - As of the latest report, Tongce Medical's total market value is 18.764 billion yuan, with a net asset value of 4.467 billion yuan and a net profit of 321 million yuan [3] - The company reported a year-on-year revenue increase of 2.68% to 1.448 billion yuan and a net profit increase of 3.67% to 321 million yuan for the first half of 2025 [3] - The company's gross margin stands at 40.75%, significantly higher than the industry average of 35.92%, and its net profit margin is 26.26%, compared to the industry average of 3.8% [3] Industry Ranking - Tongce Medical ranks 8th in total market value and 12th in net assets within the medical services industry, with a price-to-earnings ratio of 29.21, which is significantly lower than the industry average of 82.41 [3] - The company has received 9 ratings from institutions in the last 90 days, with 7 buy ratings and 2 hold ratings, and the average target price set at 52.01 yuan [4]